Bictegravir-Tenofovir alafenamide-Emtricitabine Biktarvy
Darunavir-Cobicistat-Tenofovir alafenamide-Emtricitabine Symtuza
Dolutegravir-Abacavir-Lamivudine Triumeq
Dolutegravir-Lamivudine Dovato
Dolutegravir-Rilpivirine Juluca
Doravirine-Tenofovir DF-Lamivudine Delstrigo
Efavirenz-Tenofovir DF-Emtricitabine Atripla
Elvitegravir-Cobicistat-Tenofovir alafenamide-Emtricitabine Genvoya
Elvitegravir-Cobicistat-Tenofovir DF-Emtricitabine Stribild
Rilpivirine-Tenofovir alafenamide-Emtricitabine Odefsey
Rilpivirine-Tenofovir DF-Emtricitabine Complera
Fostemsavir Rukobia
Ibalizumab Trogarzo
Maraviroc Selzentry
Dolutegravir Tivicay
Raltegravir Isentress
Doravirine Pifeltro
Efavirenz Sustiva
Etravirine Intelence
Rilpivirine EdurantSection Navigation
Section Navigation
- Module 6 Overview
Key Populations - 0%Lesson 1
HIV in Infants and ChildrenActivities - 0%Lesson 2
HIV in Adolescents and Young AdultsActivities - 0%Lesson 3
HIV in WomenActivities - 0%Lesson 4
HIV in Older AdultsActivities - 0%Lesson 5
HIV and CorrectionsActivities - 0%Lesson 6
HIV-2 InfectionActivities
Lesson 1. HIV in Infants and Children
Learning Objective Performance Indicators
- Discuss basic epidemiologic features of perinatally-acquired HIV and pediatric HIV in the United States
- Explain the timing and types of diagnostic tests used to diagnose HIV in infants less than 1 year of age and in older children
- List symptoms and classification of HIV in children using the most recent CDC surveillance case definition for pediatric HIV
- Summarize antiretroviral therapy management in children, including initiation, adverse effects, and approach to virologic failure
- Discuss opportunistic infection prevention recommendations for infants and children and how these recommendations are influenced by a child’s age and stage of HIV
About this Lesson
Learning Objective Performance Indicators
- Discuss basic epidemiologic features of perinatally-acquired HIV and pediatric HIV in the United States
- Explain the timing and types of diagnostic tests used to diagnose HIV in infants less than 1 year of age and in older children
- List symptoms and classification of HIV in children using the most recent CDC surveillance case definition for pediatric HIV
- Summarize antiretroviral therapy management in children, including initiation, adverse effects, and approach to virologic failure
- Discuss opportunistic infection prevention recommendations for infants and children and how these recommendations are influenced by a child’s age and stage of HIV
Activities in this Lesson
- Quick ReferenceHIV in Infants and Children Core Concepts
- Introduction
- Epidemiology of HIV in Children Younger than Age 13
- Staging of Pediatric HIV Disease
- Diagnosis of HIV in Infants and Children
- Clinical and Laboratory Monitoring
- Antiretroviral Treatment for Children with HIV
- Immunizations for Children Living with HIV
- Opportunistic Infections in Children
- Summary Points
Check
-On-
Learning
Questions
-On-
Learning
Questions
The Check-on-Learning Questions are short and topic related. They are meant to help you stay on track throughout each lesson and check your understanding of key concepts.